Focus on Women's and Men’s Health: Recent Episodes
ReachMD
There are real differences in men's and women's health concerns. The life expectancy gap is decreasing between men and women, but men still deal with higher rates of cardiovascular disease, prostate and testicular cancers, fluctuating testosterone levels, and fertility issues. Women’s health issues include cancer, reproductive and sexual health issues, osteoporosis prevention and management, nutrition and sports medicine. This series focuses on new developments in the diagnosis and treatment of gender-specific health issues.
Host: Ayse Tuba Kendi, MD
Guest: A. Oliver Sartor, MD
Prostate-specific membrane antigen (PSMA) is highly expressed on prostate cancer (PC) cells and can be detected in tumors using positron emission tomography imaging. Even though clinical features predict different stages of PC progression, the application of imaging to guide treatment is still evolving but gaining substantial evidence for the targeting of PSMA. With clinical research shifting paradigms for the treatment of metastatic castration-resistant prostate cancer (mCRPC), novel treatment options require adoption and effective application into clinical practice. PSMA has become an appealing target for diagnostic agents for imaging and therapeutic agents to treat mCRPC. Radionuclide emitters are being used for both cell surface expression of PSMA and the tumor microenvironment, and research has proven the therapeutic efficacy of PSMA-directed radioligand therapy (RLT).
In this educational activity, two experts will examine the role and rationale for PSMA targeted therapies and diagnostics—jointly known as theragnostics—as a revolutionary new approach to treating patients with advanced prostate cancer and will evaluate clinical trial data for PSMA-targeted RLT.
Host: Ayse Tuba Kendi, MD
Guest: A. Oliver Sartor, MD
Prostate-specific membrane antigen (PSMA) is highly expressed on prostate cancer (PC) cells and can be detected in tumors using positron emission tomography imaging. Even though clinical features predict different stages of PC progression, the application of imaging to guide treatment is still evolving but gaining substantial evidence for the targeting of PSMA. With clinical research shifting paradigms for the treatment of metastatic castration-resistant prostate cancer (mCRPC), novel treatment options require adoption and effective application into clinical practice. PSMA has become an appealing target for diagnostic agents for imaging and therapeutic agents to treat mCRPC. Radionuclide emitters are being used for both cell surface expression of PSMA and the tumor microenvironment, and research has proven the therapeutic efficacy of PSMA-directed radioligand therapy (RLT).
In this educational activity, two experts will examine the role and rationale for PSMA targeted therapies and diagnostics—jointly known as theragnostics—as a revolutionary new approach to treating patients with advanced prostate cancer and will evaluate clinical trial data for PSMA-targeted RLT.
Host: Paul Doghramji, MD
Guest: Megan Arnot
Menopause is an inevitable transition in every woman’s life, but what if engaging in a basic physiological need like sex could delay its onset? Researching this potential connection is Megan Arnot, a Ph.D. candidate in the Department of Anthropology at the University College London. As the lead author of the study, she walks us through her findings and the range of factors they investigated, like the type of sexual activity and whether or not women lived with a partner.
Host: Mario R. Nacinovich, Jr., MSc
Guest: Kara Rood, MD
A recent study following 346 pregnant patients found that 63 percent of the women were admitted into the hospital for uncertain diagnosis or delivery—all because preeclampsia has many of the same symptoms of other diseases. The good news, however, is that there’s a new test currently underway that could make the diagnosis and treatment of preeclampsia easier in order to prevent potentially dangerous outcomes for the mother and baby, as OB/GYN Dr. Kara Rood explains.
Host: Brian P. McDonough, MD, FAAFP
Human papillomavirus (HPV) infection remains one of the most common sexually transmitted infections in both females and males, with about 9 in 10 people contracting HPV at some point in their lives.
Host Dr. Brian McDonough is joined by Samantha Gottlieb, medical anthropologist and author of Not Quite a Cancer Vaccine: Selling HPV and Cervical Cancer. They explore the history of Gardasil, a vaccine developed for HPV but marketed primarily as a cervical cancer vaccine, which became embroiled in sociopolitical debates about adolescent sexuality and pediatric vaccinations.
The two discuss these precedents alongside current controversies, such as whether vaccinating both males and females will induce herd immunity, and if the benefits outweigh the risks.
Host: Matt Rosenberg, MD
Guest: Aiden Harrington, ANP, CNM
Current CDC Treatment Guidelines include transgender men and women as special populations. These guidelines recommend risk assessment based on current anatomy and sexual behaviors and screening for asymptomatic STIs based on the patient's history and sexual practices.
At a recent live event recorded in Chicago, moderator Dr. Matt T. Rosenberg welcomes Aiden Harrington, ANP, CNM from Howard Brown Health in Chicago, Illinois. Topics covered include health risks in the LGBTQ community, STI screening and treatment, and how to discuss sexuality with your patients.
Guest: Sheryl A. Kingsberg, PhD
Dr. Sheryl Kingsberg demonstrates counseling strategies clinicians can use with their patient when discussing dyspareunia in post-menopausal women.
Dr. Sheryl Kingsberg is Chief of the Division of Behavioral Medicine in the Department of OB/GYN at University Hospitals Cleveland Medical Center and Professor of Reproductive Biology and Psychiatry at Case Western Reserve University School of Medicine in Cleveland, Ohio.
Guest: David J. Portman, MD
Dr. David J. Portman demonstrates how clinicians can begin the conversation of dyspareunia with patients, as well as how to discuss the available treatment options for managing this condition in post-menopausal women.
Dr. Portman is Director Emeritus at Columbus Center for Women’s Health Research; and, Adjunct Instructor of Obstetrics and Gynecology at The Ohio State University, Columbus, OH.
Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG
Guest: Heidi Faith
Doulas have become an integral part of the obstetrics field. In recent years, a new, specialized type of doula, called the bereavement doula, has emerged. But what roles and duties are performed by this care provider?
Host Dr. Renee Allen speaks with Heidi Faith, Founder, President and CEO of StillBirthDay, a highly specialized doula program. The two talk about the unique care roles a bereavement doula can play in the labor and delivery of stillborn babies.
Host: Brian P. McDonough, MD, FAAFP
It's widely known that genetics, family history, race, and other factors all play important roles in cancer risk. But what kinds of roles do they play, specifically, and how can we leverage these understandings into better primary care?
Dr. Brian McDonough is joined by Dr. Maureen Murphy, research scientist at the Wistar Institute at the University of Pennsylvania. Dr. Murphy has spent the past twenty years studying how genes affect breast cancer risk in women, particularly for African American populations. She discusses her findings on the discovery of p53 protein variants and how this advances the role for precision medicine in treating breast cancer.
FDA medical oncologists discuss the agency’s March 2017 approval of niraparib for the maintenance treatment of patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy.
Released May 18, 2017
Host: Maurice Pickard, MD
Guest: Peter Dawson, MD
In the male-dominated world of medicine, she dared to step forward and fight for fairness—graduating from Johns Hopkins Medical School with honors in the year 1900. But for physician Dorothy Reed Mendenhall, MD, the battle for equality was just beginning.
In the name of improving the standards of care for women and infants, she faced the scorn of prejudiced doctors in an establishment marked by its unwillingness to change. Still, through the Gilded Age, two World Wars, and beyond, she kept up her fight—in the process, discovering new breakthroughs and saving lives, all while outperforming many of her male peers.
Dorothy in a Man’s World is an inside look at the life and career of Dr. Mendenhall, documented by physician and pathologist Dr. Peter Dawson. This biographical tribute to one of medicine’s great female pioneers showcases the struggles women faced to make a name for themselves in the world of health care—in addition to the drastic improvements which have been made in the specific area of care for women and their infants.
Dr. Dawson sits down with host Dr. Maurice Pickard as they explore Dr. Mendenhall's extraordinary life.
Host: Matt Birnholz, MD
Guest: Ari Brooks, MD
Guest: Brian Englander, MD
Host Dr. Matt Birnholz is joined by Dr. Ari Brooks, Director of Endocrine and Oncology Surgery and Director of the Integrated Breast Center at Pennsylvania Hospital, and Dr. Brian Englander, Clinical Assistant Professor and Chair of the Department of Radiology at Pennsylvania Hospital. Drs. Brooks and Englander discuss the hot topics within breast cancer innovations. They touch upon the increase in involvement of genetics and genomic research that is impacting breast cancer treatment options, new breast imaging modalities, and continuity of care.
Host: Matt Birnholz, MD
Guest: Robert H. Debbs, DO
Joining Dr. Matt Birnholz to discuss counseling methods for patients who are trying to conceive is Dr. Robert Debbs, Director of the Pennsylvania Hospital Maternal Fetal Medicine Network in New Jersey and Clinical Professor of Obstetrics and Gynecology at Penn Medicine. Dr. Debbs will discuss pre-conceptual counseling on a range of topics such as obesity, congenital heart disease, depression, and conceiving after a miscarriage.
Host: Matt Birnholz, MD
Guest: Paris D. Butler, MD, MPH
Host Dr. Matt Birnholz welcomes Dr. Paris D. Butler, who will be discussing breast reduction surgery for women who suffer from chronic back pain and breast cancer patients undergoing reconstructive surgery following a diagnosis. Dr. Butler will go into detail about the pros and cons of taking an immediate versus a delayed reconstruction approach and the various techniques associated.
Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG
Guest: Carmen Brown, MD
What does it take to pick up your practice and move to a foreign country? And what can be gained and lost in translation?
Host Dr. Renee Allen chats with Dr. Carmen Brown,a board-certified OB/GYN practicing in New Zealand, about her experiences and perspectives transitioning a clinical practice and family home to another continent.
Host: Ana Maria Rosario
Guest: Martin R. Chavez, MD, FACOG
From the Women's Health Annual Visit in Chicago, host Ana Maria Rosario talks with Dr. Martin Chavez, the Director of Maternal Fetal Medicine and Fetal Surgery Program at Winthrop University Hospital, about the maternal-fetal effects of the Zika virus outbreak.
Host: Jennifer Caudle, DO
Joining Dr. Jennifer Caudle to share insights about fibroid treatment updates and counseling methods is Dr. Jessica Shepherd, Assistant Professor of OB/GYN and Director of Minimally Invasive Gynecology at the University of Illinois in Chicago. Dr. Shepherd is the founder of HerViewpoint.com, an online forum for women designed to discuss all those women's health topics that are difficult to raise in doctors' offices.
Host: Alan S. Brown, MD, FACC, FAHA, FNLA
Live from the Clinical Lipid Update of the National Lipid Association in Amelia Island, FL, host Dr. Alan Brown welcomes Dr. Robert Kloner, Vice President of Translation at Huntington Medical Research Institutes and Professor of Medicine in the Cardiovascular Division of Keck School of Medicine at the University of Southern California.
Dr. Kloner discusses the cardiovascular risk factors associated with erectile dysfunction, safety and efficacy of erectile disfunction drugs, and benefits vs risks of supplementing with testosterone.
Host: Patrice L Basanta-Henry, MD, MHSc, FACOG
Approximately just 0.5% of all births occur before the third trimester of pregnancy, yet these very early deliveries result in the majority of neonatal deaths and more than 40% of infant deaths. Care for infants born at the threshold of viability, less than 24 weeks of gestation and with body weights less than 1000 grams, poses many difficult clinical, social, and ethical questions among clinicians and families.
Host Dr. Patrice Basanta-Henry speaks with guest Dr. Fyama Wenner, a maternal-fetal medicine specialist at Atlanta Maternal Fetal Medicine, about special care considerations for extremely preterm infants, as well as effective counseling strategies for families.
Host: Ana Maria Rosario
Guest: Anita L. Nelson, MD
Joining host Ana Maria Rosario at the Women's Health Annual Visit in Deerborn, MI, is Dr. Anita Nelson, professor emeritus at UCLA and professor and chair of OB/GYN at Western University in California. The two discuss patient barriers to accessing IUDs and implants in a rapidly growing contraceptive market.
Host: Brian P. McDonough, MD, FAAFP
In a survey released by the American Academy of Family Physicians (AAFP), nearly half of men reported that their health was "good" or "excellent." This marked a dramatic increase in health perceptions from men over the past decade, despite the fact that more men now live with chronic conditions such as hypertension and diabetes than ever before. What does this discrepancy between perceptions and realities tell us about the state of health care for men in America?
Joining Dr. Brian McDonough to discuss special considerations and primary care priorities for men is Dr. John Meigs, practicing generalist and President-Elect of the AAFP.
Host: Brian P. McDonough, MD, FAAFP
Egg freezing, also known as oocyte cryopreservation, has gained rapid popularity as patient populations have broadened. Once intended almost exclusively for cancer patients undergoing aggressive chemotherapy treatments, more and more healthy women are choosing this resource to expand their reproductive options later in life.
Dr. Lisa Ashe, internist and medical director for Be Well Medical Group in Alexandria, VA, speaks with Dr. Brian McDonough about her personal experience with egg freezing from three simultaneous vantage points: physician, patient, and minister.
Host: Maurice Pickard, MD
STDs are widespread in all walks of life, regardless of gender, race, social status, or education. Seduced into complacency by the notion that "it can't happen to me" many sexually active teens and young adults are stunned when they are diagnosed with an STD.
In Seductive Delusions: How Everyday People Catch STDs, author and physician Dr. Jill Grimes reveals the truths about sexually transmitted diseases through narrated accounts of young men and women, their exam room conversations with doctors, and both the physical symptoms and the emotional reactions that can accompany infection.
Host: Michael Krychman, MD
Feminine hygiene, though an important part of daily life, is rarely discussed openly,not even in clinical settings.
Host Dr. Michael Krychman sits down with Dr Alyssa Dweck, practicing gynecologist in New York and Assistant Clinical Professor at Mt. Sinai School of Medicine. They give essential tips for clinicians on how to talk to patients about feminine hygiene.
Host: Brian P. McDonough, MD, FAAFP
Guest: Charles N. Walker, MD
Dr. Charles Walker, Assistant Professor of Surgery in the Department of Urology at Yale University School of Medicine, shares clinical insights about penile prostheses, such as inflatable versus malleable devices, used as surgical gold standards to treat erectile dysfunction.
Host: Michael Krychman, MD
The primary purpose of contraception is to separate sex from procreation. However, sexual function is rarely addressed or considered in the context of making contraceptive choices.
Dr. Michael Krychman speaks with Dr. Rachel Perry, Assistant Professor of OB/GYN at the University of California-Irvine, about the various complex sexual health impacts of oral contraceptives, IUDs, condoms, and permanent sterilization procedures.
Host: Jennifer Caudle, DO
There are many widely circulated myths regarding breast cancer, such as:
- Beliefs that this disease affects women only.
- Fears that mammograms can cause cancers to spread.
- Assumptions that most patients with breast cancer have family histories positive for this disease.
Host Jennifer Caudle talks with guest Dr. Monique Gary, a fellowship-trained breast surgical oncologist at Grand View Health in Sellersville, Pennsylvania. Together, they dispel myths about breast cancer and talk about what patients can expect during a surgical oncologist appointment.
Host: Alan S. Brown, MD, FACC, FAHA, FNLA
Guest: Robert Wild, MD, MPH, D.Phil.
Recorded live at the recent Annual National Lipid Association meeting, Dr. Alan Brown welcomes Dr. Robert Wild to discuss types of dyslipidemia that clinicans may see in women of child bearing age, particularly those using hormonal contraception. The two discuss ways for clinicians to trace the source of dyslipidemia in these women, from primary to secondary causes, and how this knowledge can guide future contraception choices.
Dr. Robert Wild is Professor of OB/GYN and Adjunct Professor in Biostatistics and Epidemiology at the University of Oklahoma. He is also Adjunct Professor in Epidemiology at the University of Pittsburgh, and Adjunct Professor of Nutrition at Oklahoma State University.
Host: Shira Johnson, MD
Guest: Charles N. Walker, MD
Dr. Shira Johnson speaks with Dr. Charles Walker, Assistant Professor of Surgery in the Department of Urology at Yale University School of Medicine. The two focus on erectile dysfunction as a common complication for patients dealing with diabetes and heart disease, and ways that clinicians can help patients manage this problem through lifestyle modifications. Dr. Walker also introduces emerging pathophysiological understandings of ED as a potential predictor of diabetes.
Host: Michael Krychman, MD
Ovarian cancer is among the most highly prevalent and deadly cancers in existence, and in the struggle to care for patients and protect their quality of life, clinical standards in diagnostic screening and treatment protocols must change frequently.
Joining host Dr. Michael Krychman to discuss advances in treatment and prevention of ovarian cancer, with special focus on sexual health priorities, is guest Dr. Leslie Randall. Dr. Randall is Associate Professor of Obstetrics and Gynecology at the University of California-Irvine, and also Director of UC’s gynecologic oncology fellowship program.
Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG
Babies born before 37 weeks gestation face many challenges in their first weeks of life. For premature babies to thrive in the NICU, the American Academy of Pediatrics recommends all preterm babies weighing less than 1500 grams be fed human milk. However, this recommendation creates a dilemma for mothers who are unable to supply their own breast milk and must therefore turn to donation programs to feed their babies.
Dr. Renee Allen chats with Scott Elster, CEO of Prolacta Bioscience, about the goals of breast milk donor programs to improve health outcomes for critically ill preemies, while also reducing NICU costs.
Host: Michael Krychman, MD
Women who experience low libido often feel embarrassed, lonely, and unsure where to turn or with whom to confide. Left unaddressed, this issue can have devastating effects on relationships.
Dr. Michael Krychman sits down with Amanda Parrish, nationally recognized patient advocate for women's sexual health, to talk about hypoactive sexual desire disorder (HSDD) and the need for clinicians to foster open conversations with patients about low libido.
Host: Matt Birnholz, MD
Guest: Ronald J. Wapner, MD
Innovations in medical genetics are changing the practice of obstetrics and gynecology. With advancing knowledge of underlying genetic predispositions, doctors can provide more precisioned care plans for patients in women's health centers.
Dr. Matt Birnholz talks with Dr. Ronald J Wapner, Professor of Obstetrics and Gynecology and Director of Reproductive Genetics at Columbia University, about how the ever-changing field of medical genetics is revolutionizing OB/GYN treatment options and patient care.
[Read the Article]
An estimated 15 million Americans do some kind of rotating shift work, including overnights, evenings and early morning shifts. But can this type of shift work increase the risk of coronary heart disease? A new study examined the link between rotating night shift work and heart disease in a group of female nurses.
Researchers at Brigham and Women's Hospital used data from the Nurses' Health Studies (1 and 2), which followed participants for a twenty-four year period. They specifically looked at 189,000 women who reported their lifetime exposure to rotating night shift work. Over the course of the study period, more than 10,000 new cases of coronary heart disease were reported.
The results suggested that rotating night shift work was associated with modest risk of coronary heart disease, but further research is needed to help determine whether the association is related to specific work hours and/or individual characteristics.
[Watch more videos of The JAMA Report]
Host: Barnett Mennen, MD
Guest: Angela DeMichele, MD, MSCE
Penn Medicine’s Breast Cancer Translational Center of Excellence (TCE), known as the 2-PREVENT TCE is led by Drs. Lewis Chodosh and Angela DeMichele. 2-PREVENT TCE aims to address one of the greatest challenges in breast cancer treatment: the high rate of relapse and late treatment effects among breast cancer survivors.
Host Dr. Barry Mennen welcomes Dr. Angela DeMichele, the Alan and Jill Miller Endowed Chair in Breast Cancer Excellence, Professor of Medicine and Epidemiology, and Co-Leader of the Breast Cancer Research Program at the Abramson Cancer Center of the University of Pennsylvania School Of Medicine.
Host: Jennifer Caudle, DO
Joining Dr. Jennifer Caudle to discuss top tips in breast cancer risk, screening, and detection is Dr. Monique Gary, breast surgical oncologist at Grand View Health in Sellersville, PA. Dr. Gary earned her medical degree from Philadelphia College of Osteopathic Medicine. She completed her internship and residency at University of Massachusetts Hospital and went on to complete her fellowship at Georgetown University Hospital.
Host: Brian P. McDonough, MD, FAAFP
Guidelines in testing intervals and recommended methods for cervical cancer screening have been changing rapidly. What's the bottom line on helping primary care clinicians best protect their patients from this disease development? Joining Dr. Brian McDonough on the floors of Omnia Education's Women's Health Annual Visit in New York to discuss updated strategies drive down cervical cancer risk is Dr. Edward Mayeaux, Professor and Chairman of the Department of Family and Preventive Medicine at the University of South Carolina School of Medicine.
Host: Patrice L Basanta-Henry, MD, MHSc, FACOG
Guest: LaToya Stephens, MD
Vaginal atrophy is a painful and emotionally distressing condition affecting many women, yet many suffer in silence. For those who find traditional treatment options to be ineffective, a vaginoplasty procedure already in use for cosmetic applications has been demonstrated to help counter the most severe symptoms. Join host Dr. Patrice Basanta Henry and Dr. Benita Stephens, Board Certified Ob-Gyn and founder of Ciao Bella Medical Center & Spa in Atlanta, GA, as they discuss the benefits and risks of "vaginal rejuvenation" procedures for symptomatic vaginal atrophy.
Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG
From the American Cancer Society, ovarian cancer ranks fifth in cancer deaths among women, accounting for more deaths than any other cancer of the female reproductive system. A woman's risk of getting ovarian cancer during her lifetime is about 1 in 75. Her lifetime chance of dying from ovarian cancer is about 1 in 100. Host Dr. Renee Allen is joined by Dr. Evelyn Reynolds to discuss critical updates in ovarian cancer, specifically dispelling the myth about ovarian cancer being a "silent killer." Dr. Reynolds an Associate Professor and Division Director of Gynecologic Oncology at the Morehouse School of Medicine. She is board-certified in General Obstetrics and Gynecology and also Gynecologic Oncology.
Host: Michael Krychman, MD
Dr. Michael Krychman interviews Dr. Brett Worly, Assistant Professor of Obstetrics and Gynecology at the Ohio State University School of Medicine. Dr. Worly talks about successful integrations of sexual medicine into evaluative, diagnostic, and treatment protocols in women's health practice, and how this progression led to the formation of a novel women's sexual health clinic at OSU.
Host: Thomas C. Wright, Jr., MD
How should clinicians educate patients on recommended timing intervals for receiving pap smears based on updated guidelines? And for those patients who receive a positive HPV test, what counseling strategies and treatment pathways would be most helpful?
Joining Dr. Thomas Wright from Omnia Education's Women's Health Annual Visit in Boston, MA is Dr. Dana Gossett, Division Chief of General Obstetrics and Gynecology at Northwestern Medical Faculty Foundation and Associate Professor at Northwestern University Feinberg School of Medicine.
Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG
Recent guidelines have been released on the recommended frequency of conducting pap smears, which has caused considerable debate between health care providers. How should non-gynecologists interpret these guidelines, as well as opposing views from specialists, for best performance of pap smears? And why in the age of DNA testing is this still an important exam? ReachMD host Dr. Renee Allen welcomes Dr. Jocelyn Slaughter-Moore, practicing obstetrician & gynecologist in private practice at Heras Healthcare for Women, to address these and other questions. Dr. Slaughter-Moore is an attending physician at Clearview Regional Medical Center and Eastside Medical Center in Georgia.
Host: Patrice L Basanta-Henry, MD, MHSc, FACOG
Guest: Kenan R. Omurtag, MD
It is estimated that 3 to 5% of all couples desiring pregnancy will suffer recurrent pregnancy loss (RPL). What are our current understandings of this unfortunate condition, and how can patients be treated to support successful future pregnancies? Host Dr. Patrice Basanta-Henry discusses the many facets of this clinical issue with Dr Kenan Omurtag, Assistant Professor of the Division of Reproductive Endocrinology and Infertility at Washington University School of Medicine in St Louis, Missouri.
[Read the Article]
Rates of genetic testing for BRCA1 and BRCA2 mutations have increased among younger women diagnosed with breast cancer, according to a new study. The study focused on nearly 900 women diagnosed with breast cancer at age 40 or younger. Researchers looked at rates of genetic testing, barriers to testing, and how the test results affected treatment decisions.
In 2006, the rates of BRCA testing were in the seventy percent range and by 2012 that proportion rose to ninety-five percent. While the majority of women reported being tested for BRCA 1 and 2, many were not, and a small minority reported that no one had discussed genetic risk or testing options. The study authors note that the overall goal of genetic testing is to help women make informed treatment decisions. Assessment of a young woman's genetic risk after a breast cancer diagnosis can affect treatment decisions and the results can also have health implications for her relatives.
[Watch more videos of The JAMA Report]
Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG
What is the role and importance of the Ob-Gyn Oncologist, especially for women diagnosed with pelvic cancers? What are some barriers patients face in seeing an Ob-Gyn Oncoloogist? And how can clinicians better partner with this group of specialists? In this episode, host Dr. Renee Allen explores answers to these questions with guest expert Dr. Evelyn Reynolds, board certified physician in both General Obstetrics & Gynecology and Gynecologic Oncology. She is also an Associate Professor and Division Director of Gynecologic Oncology at the Morehouse School of Medicine.
Host: Michael Krychman, MD
Host Dr. Michael Krychman welcomes Dr. Risa Kagan to discuss the intimacy and sexuality issues that patients face when they are dealing with fragility fractures. Dr. Kagan is Clinical Professor of Obstetrics, Gynecology, and Reproductive Sciences at the University of California, San Francisco. Since October 2005, she has been practicing gynecology with the East Bay Physicians Medical Group. Dr. Kagan is also a medical consultant at the Foundation for Osteoporosis Research and Education (FORE), and principal investigator on several clinical research trials involving women’s health. She is a North American Menopause Society (NAMS) certified Menopause Practitioner and is certified by the International Society of Clinical Densitometry.
Host: Brian P. McDonough, MD, FAAFP
Reporting from the Caribbean island of Bonaire, Dr. Brian McDonough provides an update on local public sentiments and concerns around the continuing spread of Zika virus infections across the world.
Host: Stephen M. Cohen, MD, FACOG
Standards in cervical cancer detection methods have come a long way in the past 30 years, from cervical cytology to HPV co-testing and HPV primary screening. How did the OB/GYN community get here, and is the direction of current practice standards in sync with clinical preferences nationwide?
Joining Dr. Stephen Cohen to discuss these and other questions at the Women's Health Annual Visit in Houston, TX is Dr. Thomas Cox, former Director of Gynecology and Colposcopy at the University of California-Santa Barbara Health Services Center and Past-President of the American Society of Colposcopy and Cervical Pathology.
[Read the Article]
Women facing infertility often turn to in vitro fertilization (IVF). Although IVF technology has improved, there is still a widely held belief that if a woman doesn't experience a successful live birth after three or four IVF cycles, her chances of a successful live birth are very low. A new study looked at IVF success rates after repeated treatment cycles well beyond the third or fourth attempts.
Researchers from the University of Bristol, in England reviewed the medical records of almost 160,000 women in the United Kingdom who underwent nearly 260,000 full IVF cycles between 2003 and 2010. They examined live birth rates among these women thru 2012.
They found that women under the age of forty who used their own eggs had a 33 percent success rate within the first cycle. This rate remained at above 20 percent up to and including the fourth cycle. By the sixth cycle, women had a cumulative live birth rate of 68 percent. Women between ages forty and forty-two, also saw an increased success rate up until the ninth cycle.
Overall, researchers reported that patients had an increased chance of success up to the ninth …
Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG
Guest: Patrice L Basanta-Henry, MD, MHSc, FACOG
Cesarean sections are among the most common surgical procedures performed in the U.S. Yet despite its commonality, patients undergoing cesarean deliveries are far more likely to have difficult and unsatisfatcory birth experiences, leading to higher incidence rates of postpartum depression, bonding difficulties, and unsuccessful breast feeding. A novel approach to address this issue is being called the Family-Centered cesarean delivery. How does it work, and what are the distinct differences from traditional protocols?
Host Dr. Renee Allen welcomes Dr. Patrice Basanta Henry, practicing Ob-Gyn & MFM at Atlanta Maternal Fetal Medicine, an affiliate of Mednax National Medical Group. Dr. Basanta-Henry’s clinical interests include intrauterine growth restriction and endocrine disorders in pregnancy.
Host: Thomas C. Wright, Jr., MD
Guest: David Gandell, MD
For women entering menopause, increased pain during intercourse is a common but little discussed problem which dramatically affects quality of life. While there are several treatment options available, many clinicians aren't up to date. Joining host Dr. Tom Wright to discuss current therapies for painful intercourse in this patient population is Dr. David Gandell, Clinical Professor of OB/GYN at the University of Rochester in Rochester, NY.
[Read the Article]
The most common operation done worldwide is the cesarean or C-section. Cesarean delivery is lifesaving for obstructed labor and other obstetrical emergencies; however, as with any surgical procedure, there are risks of complications and overuse can be harmful to both mothers and newborns. There were about 22.9 million cesarean deliveries worldwide in 2012. Based on older analyses from the mid-1980s, the World Health Organization (WHO) recommends that cesarean delivery rates should not exceed 10 to 15 per 100 live births.
In a study in the December 1 issue of JAMA, Harvard Researchers examine the relationship between cesarean delivery rates and maternal and infant death, and other adverse outcomes in children following planned cesarean delivery. The results indicate that the optimal cesarean delivery rate in relation to maternal and neonatal mortality is approximately 19 per 100 live births. Higher cesarean delivery rates were not associated with better outcomes in mothers and children.
[Watch more videos of The JAMA Report]
Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG
Pregnancy loss can occur in any trimester of pregnancy and for several possible reasons. For clinicians who treat pregnant patients, delivering the bad news of pregnancy loss is an avoidable part of practice. How do health care professionals best counsel these patients and their loved ones through these difficult times? Host Dr. Renee Allen joins Dr. Jocelyn Slaughter-Moore, practicing OB/GYN at Heras Healthcare for Women and attending physician at Clearview Regional Medical Center in Monroe, GA, to discuss counseling and coping strategies for patients who have experienced pregnancy loss.
Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG
In the US, more than one half of pregnant women are overweight or obese, and 8% of reproductive-aged women are extremely obese, putting them at a greater risk of pregnancy complications. In this episode, we review the magnitude of the problem, the anatomic and physiologic factors specific to the obese patient, and the maternal and fetal complications that can occur. Host Dr. Renee Allen welcomes Dr. Patrice Basanta Henry, an Ob-Gyn & MFM at Atlanta Maternal Fetal Medicine, an affiliate of Mednax National Medical Group. Dr. Basanta-Henry’s clinical interests include intrauterine growth restriction and endocrine disorders in pregnancy.
Host: Ana Maria Rosario
Guest: Anita L. Nelson, MD
Current clinical definitions and terminology for vaginal bleeding often fail to clarify frequency, duration, and volume. Moreover, standards of treatment sometimes differ between obstetric and gynecological points of view. Taken together, the risks for misclassifying and mistreating women with acute excessive vaginal bleeding are preventably high.
Joining host Ana Maria Rosario at Omnia Education's Women's Health Annual Visit in Pasadena, CA to discuss key considerations for acute excessive vaginal bleeding is Dr. Anita Nelson, Professor Emeritus at the David Geffen School of Medicine at UCLA.
[Read the Article]
In the United States, it is estimated that approximately 230,000 women will be diagnosed with breast cancer, and more than 40,000 will die from the disease this year alone. Early detection using mammography remains the best way to prevent premature death from breast cancer. A panel of experts examined decades of research to update the American Cancer Society's (ACS) recommendations for breast cancer screening. Based on this review, the 2015 recommendations for breast cancer screening for women at average risk of cancer include the following:
- Women should undergo regular screening mammography starting at age 45.
- Women 45 to 54 years of age should be screened annually.
- Women 55 years and older should transition to every other year screening or have the opportunity to continue annual screening.
- Women should have the opportunity to begin annual screening between the ages of 40 and 44 years.
- Women should continue screening mammography as long as their overall health is good and they have a life expectancy of 10 years or longer.
- Clinical breast examination is not recommended for breast cancer screening among average-risk women of any age.
[Watch more videos of …
Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG
Host Dr. Renee Allen welcomes Dr. Victoria Green, renowned breast cancer researcher and OB/GYN clinician. Dr. Green is an Associate Professor in the Department of Gynecology & Obstetrics at Emory University School of Medicine. She will review USPSTF recommendations of biennial mammograms compared to ACOG's recommendations, as well as differences in how we define 'breast awareness' versus breast self-examination. Join the discussion!
Host: Kathy King, RDN
Guest: Patsy Catsos
FODMAPs are short chain carbohydrates (oligosaccharides), disaccharides, monosaccharides and related alcohols that are poorly absorbed in the small intestine. For patients with irritable bowel syndrome, Celiac disease, or inflammatory bowel disorders, ingestion of these carbohydrates can significantly worsen disease symptoms. How are low FADMAP diets constructed to control this nutritional issue, and where do patients need help and guidance maintaining these diets?
Host Kathy King welcomes dietitian Patsy Catsos, author of IBS Free at Last. Ms. Catsos has a private practice in Portland, ME and has been an early adopter of the FODMAP approach for patients with functional bowel disorders.
Host: Kathy King, RDN
Guest: Lily Nichols
Controlling blood sugar and weight gain in expectant patients with gestational diabetes can be challenging. But the move toward lower carbohydrate diets for these patients has shown promise in controlling diabetic progression through pregnancy. Joining host Kathy King to discuss the mechanisms and rationales behind this nutritional guidance is dietitian and certified diabetes educator Lily Nichols, author of Real Food for Gestational Diabetes.
Host: Kathy King, RDN
Guest: Angela Grassi
Polycystic Ovary Syndrome, or PCOS, is the top cause of female infertility in the United States. Patients with PCOS often ask whether nutritional choices can affect both their quality of life and even their fertility. How should the clinician respond?
Joining host Kathy King to investigate nutrition therapy for PCOS is dietitian Angela Grassi, author of PCOS: The Dietitian's Guide. Ms. Grassi is the founder of the PCOS Nutrition Center in Bryn Mawr, PA, dedicated to advocacy, education, and evidence-based research of this syndrome.
Host: Michael Krychman, MD
Guest: Sheryl A. Kingsberg, PhD
Flibanserin's approval by the FDA for women with hypoactive sexual desire disorder (HSDD), touted by the press as the "Pink Viagra," created an enormous amount of media hype across the nation. But the facts on this drug's mechanism of action, intended benefits, adverse effects, and efficacy borne in clinical trials have gone largely under the radar.
Joining Dr. Michael Krychman to discuss the rise of flibanserin and its key takeaways for clinicians is Dr. Sheryl Kingsberg, Chief of the Division of Behavioral Medicine in the Department of OB/GYN and Professor in the Departments of Reproductive Biology and Psychiatry at Case Medical Center University Hospitals in Cleveland, Ohio.
Host: Brian P. McDonough, MD, FAAFP
Dr. Brian McDonough welcomes Dr. Liz Joy, President-Elect of the American College of Sports Medicine, President of the Female Athlete Triad Coalition, and Adjunct Professor of Family & Community Health at the University of Utah School of Medicine. Their discussion centers on health maintenance for female athletes and the special factors that must be considered to care for this unique patient population.
Host: Jennifer Caudle, DO
Guest: Renée Simone Yolanda Allen, MD, MHSc., FACOG
In the past 20 years, rates of bariatric surgery have risen more than 800%. Of the number of bariatric procedures performed every year, women of reproductive age account for the vast majority of patients. What are the obstetric and gynecological effects of these various surgical procedures on female patients, and how can potential complications be prevented? Host Dr. Jennifer Caudle welcomes Dr. Renee S. Allen, Board certified OB/GYN and hospitalist, Fellow of ACOG, and Masters of Health Sciences from Atlanta, Georgia, to discuss OB/GYN counseling strategies for women who have undergone or intend to undergo bariatric surgery.
Host: Jennifer Caudle, DO
Guest: Renée Simone Yolanda Allen, MD, MHSc., FACOG
Host Dr. Jennifer Caudle welcomes Dr. Renee S. Allen, Board certified OB/GYN and hospitalist, Fellow of ACOG, and Masters of Health Sciences from Atlanta, Georgia. Dr. Allen shares her expertise as an OB/GYN hospitalist, the growing support from ACOG in this new arena, and the goals of an emerging subspecialty.
Host: Brian P. McDonough, MD, FAAFP
Dr. Brian McDonough welcomes Dr. Gregory Weinstein, Professor and Vice Chair and the Director of the Division of Head and Neck Surgery. He is the Co-Director of The Center for Head and Neck Cancer in The Department of Otorhinolaryngology: Head and Neck Surgery at the Hospital of the University of Pennsylvania. The two discuss a dramatic rise in HPV-related cancers over the past decade, and what clinicians need to be aware of in assessing their patients for these indidious diseases.
[Read the Article]
The popularity of testosterone supplementation among older men has increased substantially over the past decade. However, the risks and benefits of long-term administration are still unclear. A new study examined whether using testosterone supplements affected the development of atherosclerosis (hardening of arteries), which is linked to heart attack and stroke.
Researchers from Brigham and Women's Hospital in Boston studied more than 300 men who were sixty years of age and older, in relatively good health, and had low or low-normal testosterone levels. Half the men applied a testosterone gel daily to the skin for three years, while the other half were given a placebo gel. During the course of the trial, hardening of the arteries was measured in the carotid and coronary arteries, which supply the brain and heart.
Results were that during the three year study, there was no significant effects in terms of hardening of the carotid or coronary arteries. Testosterone supplementation also did not improve overall sexual function or health-related quality of life.
[Watch more videos of The JAMA Report]
JAMA Report videos provided pursuant to license. ©2015 American Medical Association, publisher of JAMA® and The JAMA Network® …
[Read the Article]
An increasing number of pregnant women are undergoing noninvasive prenatal testing to help identify fetal genetic abnormalities. This is done using a blood test that looks at the DNA of both the mother and fetus. In a small percentage of these tests, the results appear abnormal, but the baby's genetics are later shown to be normal. A new study examined if the rare diagnosis of maternal cancer could be one cause of such discrepancies. The study is being released to coincide with its presentation at the 19th International Conference on Prenatal Diagnosis and Therapy in Washington, D.C.
Researchers at Tufts Medical Center in Boston examined more than 125,000 noninvasive prenatal test results over the course of a two year period. Approximately 3,800 women had abnormal test results, and ten of those women were subsequently diagnosed with cancer. Medical records and additional genetic information were examined in eight of those women to look for patterns suggestive of underlying cancer.
Based on the results of the study, researchers estimate there is between a twenty and forty-four percent risk of maternal cancer if an abnormal number of chromosomes are detected. Further studies are needed to fully understand …
Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies Diana W. Bianchi, MD; Darya Chudova, PhD; Amy J. Sehnert, MD; Sucheta Bhatt, MD; Kathryn Murray, MS; Tracy L. Prosen, MD; Judy E. Garber, MD; Louise Wilkins-Haug, MD, PhD; Neeta L. Vora, MD; Stephen Warsof, MD; James Goldberg, MD; Tina Ziainia, MD; Meredith Halks-Miller, MD JAMA. 2015;314(2):162-169. doi:10.1001/jama.2015.7120 Importance: Understanding the relationship between aneuploidy detection on noninvasive prenatal testing (NIPT) and occult maternal malignancies may explain results that are discordant with the fetal karyotype and improve maternal clinical care.
Objective: To evaluate massively parallel sequencing data for patterns of copy-number variations that might prospectively identify occult maternal malignancies.
Design, Setting, and Participants: Case series identified from 125 426 samples submitted between February 15, 2012, and September 30, 2014, from asymptomatic pregnant women who underwent plasma cell-free DNA sequencing for clinical prenatal aneuploidy screening. Analyses were conducted in a clinical laboratory that performs DNA sequencing. Among the clinical samples, abnormal results were detected in 3757 (3%); these were reported to the ordering physician with recommendations for further evaluation.
Exposures: NIPT …
Dr. Carol Burke, Director of the Center for Colon Polyp and Cancer Prevention at the Cleveland Clinic, unveils ongoing but underrecognized gender disparities in the practice of gastroenterology, such as differences in academic vs private practice opportunities, average salaries and hours worked, rates of promotion and partnerships, and male-modeled endoscopic equipment designs. Dr. Burke then explores gender disparities in GI care for patients with colorectal cancer, including differences in efficacy of colorectal cancer screening, male vs female morbidity and mortality rates, and even the underlying biologies of cancers themselves.
Host: Matt Birnholz, MD
Most women will readily testify that pelvic examinations are unpleasant experiences; they can be physically painful and induce anxiety. But recent studies have also indicated that examinations of asymptomatic, average-risk woman may lead to unexpectedly high rates false positives and unnecessary followup tests. So the perennial question resurfaces: are routine pelvic examinations more trouble than they're worth?
Join Dr. Matt Birnholz and guest Dr. Hannah Bloomfield, Chief of Research at the Minneapolis VA Medical Center, speaking at ACOG’s annual scientific meeting. They focus on the latest research behind this question of whether routine pelvic examinations are really necessary for monitoring patient health, and the potential pros and cons of abandoning this practice in annual OB/GYN checkups.
Host: Michael Krychman, MD
As many clinicians have become increasingly aware, the problem of obesity involves a complex interplay of habits and hormones, influenced by genetic predispositions and cultural practices alike. Whereas the supposed magic bullets of weight loss pills and fad diets are always in high demand, few to none have demonstrated consistent benefit for patients, and the struggle to avoid the "yo yo effect" of regained weight goes on.
Sexual health problems represent some of the most difficult issues reported by patients who are obese, but rarely are these complaints properly registered or addressed by clinicians. Joining Dr. Michael Krychman at ACOG’s annual scientific meeting to focus on this neglected aspect of obesity is Dr. Maida Taylor, Clinical Professor of OB/GYN and Reproductive Sciences of the University of California-San Francisco. They discuss counseling strategies and interventions for patients striving toward better sexual health as they pursue more healthy, stable weight.
Host: Michael Krychman, MD
Low libido, a condition affecting an estimated 10% of women, can develop at any age and be attributed to several factors in a woman’s life, from lifestyle changes to medication and procedural side effects.
Join host Dr. Michael Krychman and Dr. Leah Millheiser, Director of Female Sexual Medicine at Stanford University School of Medicine, on the floor of ACOG’s annual scientific meeting. They discuss current knowledge gaps in recognizing and treating low libido, and the importance of sexual health psychology within therapeutic approaches.
Host: Matt Birnholz, MD
Many people believe that exercise during pregnancy is detrimental to the health of the fetus. This belief seems to have come from an outdated study that the fetus’s heart rate drops if the mother exercises. More recent studies, however, have supported a counterposition that exercise during pregnancy is safe and can actually be beneficial for both the mother and fetus.
Join Dr. Matt Birnholz and Dr. Linda Szymanski, Medical Director of Labor and Delivery at Johns Hopkins Hospital at the Johns Hopkins School of Medicine. They discuss the latest research on exercise during pregnancy, from benefits to harms, and how clinicians can counsel patients on the "right" amount of exercise during this life period.
Host: Matt Birnholz, MD
Guest: Maureen Whelihan, MD
There is a stigma around sex in the United States. That stigma makes it difficult both for patients to disclose details about their sex lives in clinical settings and for physicians to ask patients about sex. Consequentially patients may have treatable but unaddressed sexual problems because their physicians don't know those problems exists.
Join Dr. Matt Birnholz and Dr. Maureen Whelihan, President of The Center for Sexual Health and Education in West Palm Beach, Florida, as they discuss case stories spanning the various ages and stages of sexual health, and their implications in helping physicians and patients talk about sex.
Host: Michael Krychman, MD
For women in their 40's and 50's, approximately one in four will develop a pelvic floor disorder such as urinary incontinence. By the age of 80, that prevalence rises to more than 50 percent. The struggle with a pelvic floor disorder has lasting effects on a woman's sexual health, leading to numerous psychosocial and physical consequences in turn. But of equal concern to many patients dealing with the symptoms of their disorder is the potential aftermath of reconstructive surgical treatments, such as mesh slings, due to their troubling complication rates. Are these concerns justified, and if so, how can the risks be mitigated by both physicians and patients?
Joining Dr. Michael Krychman to discuss the misconceptions versus realities of pelvic floor disorder treatments is Dr. Cheryl Iglesia, Professor in the departments of OB/GYN and Urology at the Georgetown University School of Medicine, and Drector of the Female Pelvic Medicine and Reconstructive Surgery section of Medstar Washington Hospital Center in Washington, DC.
Host: Matt Birnholz, MD
Studies in the field of anthropology have shown that having a healthy grandmother plays a critically positive role in family cohesion. But the wholistic, personalized health needs of women in their elder years are not always recognized. This care disparity is all the more prominent in general OB/GYN practice, but thanks to the work of a select few, the trends may be about to change.
Dr. Matt Birnholz speaks with Dr. Sarah Berga, Professor and Chair of OB/GYN at Wake Forest School of Medicine at ACOG’s annual meeting in San Francisco. They discuss maintaining grandmothers' health across both physiological and psychological spectra, and how this attention in care fundamentally changes larger family units for the better.
Host: Michael Krychman, MD
Many clinicians think that one of the most dangerous things a woman will ever do in her life is to carry and conceive a child. Stemming from this belief, several misconceptions have risen within the medical community, and by extension the general public, concerning risks of sexual activity during pregnancy. Joining host Dr. Michael Krychman at ACOG's annual scientific meeting to clarify the facts versus myths on sexuality during and after this important life event is Dr. Haywood Brown, Professor and Chair of the Department of Obstetrics and Gynecology at Duke University Medical Center.
Host: Maureen Whelihan, MD
The increasingly recognized concept of a clinician's "work-life balance" is critical to thriving and avoiding burnout, but the philosophy behind this balance remains poorly understood. Some argue that adequate time alottment to one's priorities is the key factor in sustaining a positive medical career trajectory, but a select few believe that time allocation alone is not enough. Dr. Michael Foley, Chairman of the Department of Obstetrics and Gynecology at Banner University Medical Center-Phoenix, argues in favor of what he calls work-life harmony, where aspects of meaningfulness, relationships, and wellbeing better guide one's life and career decisions. Joining host Dr. Maureen Whelihan at ACOG's Annual Scientific Meeting in San Francisco, Dr. Foley applies a martial arts-centered perspective on medical careers based on his extensive experience as a seventh-degree black belt and the founder of The Center for Humane Living.
Host: Michael Krychman, MD
The market for sexual health products and accessories, from moisturizers to lubricants to self-stimulators, is very large, and this creates confusion among patients and physicians alike as to which types of products are most helpful for specific sexual health problems. To address ways to gauge the safety and efficacy of sexual health products on the market, particularly for perimenopausal patients with special needs, Dr. Michael Krychman welcomes Dr. Barb Depree, gynecologist, menopause care specialist, and founder of MiddlesexMD, a website providing information and recommended products for women's sexual health.
Host: Matt Birnholz, MD
Dr. Matt Birnholz welcomes Dr. Mark DeFrancesco, 66th President of The American College of Obstetricians and Gynecologists, to the program. Dr. DeFrancesco looks back at the accomplishments of his immediate predecessors, and reflects on the three-fold initiative to which he will dedicate his efforts on behalf of ACOG to advance the OB/GYN specialty for years to come.
Dr. DeFrancesco is managing partner at Westwood Women’s Health in Waterbury, Connecticut, a division of Women’s Health Connecticut. He is a founding member of this organization, and served as its chief medical officer for many years.
Host: Matt Birnholz, MD
In the past several years, endometrial ablation has become an increasingly utilized method for minimalizing heavy menstrual bleeding. What's more, this procedure has since been brought into the outpatient setting. But what do clinicians who are considering bringing this procedural practice into their offices need to know before moving forward?
Joining Dr. Matt Birnholz to discuss the benefits and limitations of in-office endometrial ablation is Dr. Monte Swarup, Partner at New Horizons Women’s Care from the Arizona OB/GYN Affiliates, and Clinical Assistant Professor at Midwestern University in Phoenix, AZ.
Host: Matt Birnholz, MD
Dr. Matt Birnholz welcomes Dr. Jeanne Conry, 64th President of The American Congress of Obstetricians and Gynecologists,
Host: Matt Birnholz, MD
Dr. Matt Birnholz welcomes Dr. Tom Gellhaus, President-Elect of The American College of Obstetricians and Gynecologists, to discuss his vision for ACOG's initiatives to come, inspired in part by both his unique clinical training background and his extensive legislative activity experience on behalf of OB/GYN specialists nationwide.
Dr Gellhaus is Clinical Associate Professor of OB/GYN and Director of General OB/GYN at the University of Iowa Hospitals and Clinics in Iowa. City.
Host: Michael Krychman, MD
For years, women's sexual health matters have been relatively ignored in both clinical practice and the public eye despite consistently heavy media attention drawn towards men's sexual issues and associated therapeutic products. But there is recent evidence that the tide of public awareness is beginning to change, and that's women's sexual health is becoming more openly discussed across medical, public, and corporate entities. Joining Dr. Michael Krychman to qualify this new trend and examine ways to open communication about sexual health with women in clinical practice is Dr. Alyssa Dweck, assistant clinical professor of OB/GYN at the Mount Sanai School of Medicine and expert in women's sexual health and dysfunction.
Most women in the United States will develop fibroids at some point in their lives. But the range of issues experienced is very wide, from asymptomatic disease to debilitating illness. Joining Dr. Renee Matthews to examine the mysterious etiology and pathogenesis, quality of life impacts, and modern medical and surgical approaches to fibroids is Dr. Jessica Shepherd, Assistant Professor of Clinical Obstetrics and Gynecology and the Director of Minimally Invasive Gynecology at the University of Illinois College of Medicine in Chicago. Dr. Shepherd is also founder of Her Viewpoint, an online community empowering women about their health.
Host: Matt Birnholz, MD
Placenta accreta, also known as invasive placentation, is on the rise in US labor and delivery wards. It’s also potentially deadly, and healthcare professionals need to know how to detect it quickly and manage it safely.
Joining Dr. Matt Birnholz at Omnia Education’s Women’s Health Annual Visit in New York to discuss the types, risks, and therapeutic approaches for placenta accreta is Dr. Jordan Perlow, Director of Maternal Fetal Medicine at Banner Good Samaritan Medical Center in Phoenix, AZ, and Associate Clinical Professor of OB/GYN at the University of Arizona School of Medicine.
Host: Matt Birnholz, MD
The "FDA Jury" is out on treatment for uterine fibroids, and it’s not favorable to the practice of laparoscopic power morcellation. That update, and more importantly an expert practitioner’s perspectives on the FDA's suggested recommendations, is the focus of this interview. Joining Dr. Matt Birnholz to discuss the current landscape in uterine fibroid treatments, and the changing perceptions on power morcellation procedures, is Dr. Michael Randell, practicing OB/GYN in the Department of Obstetrics and Gynecology at Northside Hospital in Atlanta, GA. Dr. Randell is a Diplomat of the American Board of Obstetrics and Gynecology and the National Board of Medical Examiners.
Host: Prathima Setty, MD
Post-menopausal patients have many options and choices for hormone therapy. But what are the issues and increased risks, if any? What are the latest updates from recent hormone therapy clinical trials and how does this impact clinical practice? Host Dr. Prathima Setty welcomes Dr. JoAnn V. Pinkerton to discuss various hormone therapy options and the latest updates in this area of concern for our patients.
About NAMS The interview was conducted live at The North American Menopause Society (NAMS) 2014 meeting. Founded in 1989, NAMS is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000 leaders in the field-including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education-makes NAMS uniquely qualified to serve as the definitive …
Host: Bruce Japsen
Guest: Mark Frohlich, MD
The cancer treatment Provenge, known as a "therapeutic vaccine," was approved by the Food and Drug Administration in April, 2010 as a novel way to attack prostate tumors. But this is more than the story of a new treatment. Host Bruce Japsen learns about the long path to FDA approval for this unique therapy that some see as a watershed development in oncology, from Dr. Mark Frohlich, senior vice president of clinical affairs and chief medical officer of Dendreon Corporation, the Seattle-based biotech company that manufactures Provenge.
Host: Maurice Pickard, MD
Guest: Abraham Morgentaler, MD
It is widely believed that testosterone therapy for men with low testosterone can lead to an increased risk of prostate cancer. Dr. Abraham Morgentaler, associate clinical professor of urology at Harvard Medical School and author of the book Testosterone for Life, recalls the fascinating story of how this idea of high testosterone levels increasing the risk of prostate cancer originated, and suggests that in fact, the opposite might be true. What evidence supports boosting testosterone levels in men with low levels of the hormone, and that this might not raise a man's risk of developing prostate cancer? Hosted by Dr. Maurice Pickard.
Host: Shira Johnson, MD
Guest: Stephen Schwartz, PhD
Approximately 8000 men are diagnosed every year with testicular cancer in the United States. A first-of-its-kind study looked at whether or not marijuana use increases the risk. Dr. Stephen Schwartz, one of the researchers on the study and professor of epidemiology at the University of Washington, discusses his findings with host Dr. Shira Johnson. The two discuss how the research was conducted, who took part, and what needs to be done in the future to find more definitive answers.
Guest: David Soper, MD
Host: Lisa Mazzullo, MD
The number of women being treated for sexually transmitted infections in the United States is growing at an alarming rate, especially among women between the ages of 19 and 24. One of the biggest obstacles in treating these infections is persuading primary physicians to screen at-risk patients. Dr. David Soper, director of the division of gynecology and general obstetrics at the Medical University of South Carolina, discusses with host Dr. Lisa Mazzullo the treatment options for women and their partners, screening strategies and new trends in treating this ever-growing problem for young women.
Host: Lisa Mazzullo, MD
Guest: Jane Salmon, MD
Twenty years ago, women who suffered from lupus were discouraged from having children; today women with lupus are successfully having healthy babies. Doctors have found that counseling lupus patients prior to conception significantly increases the chances of a healthy pregnancy. Dr. Jane Salmon, professor of medicine at Weill Medical College in New York, joins host Dr. Lisa Mazzullo to talk about her groundbreaking research for pregnant women dealing with this autoimmune disease.
Host: Lauren Streicher, MD
Guest: Michael Holick, PhD, MD
It seems these days patients know more about the benefits of Vitamin D than their physicians. Doctors are soaking up the information and making sure their patients are taking the proper levels of Vitamin D. Dr. Michael Holick, professor of medicine, physiology and biophysics and director of the Bone Health Care Clinic and the Heliotherapy, Light, and Skin Research Center at Boston University Medical Center, joins host Dr. Lauren Streicher to discuss the proper dosage, risk factors, geographical factors and benefits of Vitamin D.
Guest: Judith Florendo
Host: Lauren Streicher, MD
Chronic pelvic pain, incontinence and dyspareunia prompt many women to seek the help of their gynecologist. What most women don't know is that the next step in their treatment may be a visit to a physical therapist, for pelvic floor physical therapy. Ms. Judith Florendo, the Midwest regional representative in the women's section of the American Physical Therapy Association, joins host Dr. Lauren Streicher to talk about this growing area of women's health. Ms. Florendo explains how therapists go about evaluating their patients for treatment and who can benefit from this type of therapy.
Guest: Aine Collier, EdD
Host: Leslie P. Lundt, MD
Rarely do we encounter an issue in medicine as divisive as contraception. Author Aine Collier from the University of Maryland discusses the history of birth control with host Dr. Leslie Lundt.
Guest: Jonathon Moreno, PhD
Host: Maurice Pickard, MD
Dr. Johnathan Moreno discusses the implantation of DNA from two parents into an egg that has its nucleus removed to prevent diseases caused by genetic variants in the cytoplasmic mitochondria. Who is the mother? Join host, Dr. Maurie Pickard for an interesting discussion.
Guest: Sherman Elias, MD
Host: Bruce Japsen
Medical care for women is not just about delivering babies, but providing medical care at one location for all stages of their lives. Dr. Sherman Elias of Northwestern University's obstetrics and gynecology department tells the Chicago Tribune's Bruce Japsen about the move by U.S. hospitals to care for women at each and every stage of their lives.
Guest: Dan Shapiro, PhD
Host: Susan Dolan, RN, JD
Dr. Dan Shapiro, Director of the Medical Humanities Program and Professor of Clinical Psychiatry at the University of Arizona in Tuscon, Arizona, discusses his book, Delivering Amelia: The Story of a Young Gifted Obstetrician's Mistake and the Psychologist Who Helped Her.
Host: Lauren Streicher, MD
Guest: Marla Mendelson, MD
Marfan Syndrome, an inherited connective tissue disorder, affects 1 in 10,000 to 1 in 20,000 individuals. Women with Marfan Syndrome have a wide range of abnormalities involving the lungs, skin, ocular, musculoskeletal and cardiovascular systems. Today we are joined by Dr. Marla A. Mendelson, an assistant professor of Medicine at Northwestern University’s Feinberg School of Medicine, and director of the Women’s Cardiology program of the Bluhm Cardiovascular Institute of Northwestern Memorial Hospital which has just opened a clinic devoted to the management of women with Marfan syndrome.